Cleared Traditional

K091377 - BD FLU+ SYRINGE

K091377 is an FDA 510(k) clearance for BD FLU+ SYRINGE, manufactured by Becton, Dickinson & CO. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K091377 · Becton, Dickinson & CO · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2009
Decision
52d
Days
Class 2
Risk

K091377 is an FDA 510(k) clearance for the BD FLU+ SYRINGE. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Becton, Dickinson & CO (Franklin Lakes, US). The FDA issued a Cleared decision on July 2, 2009 after a review of 52 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton, Dickinson & CO devices

FDA 510(k) Submission Details - K091377

510(k) Number K091377 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 2009
Decision Date July 02, 2009
Days to Decision 52 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 129d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 549
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K091377.
SHINA INSULIN SYRINGE-INCLUDING ACCU-SURE INSULIN SYRINGES
K091167 · Shina Corp. · Aug 2009
EASY.TOUCH INSULIN SYRINGE
K091474 · Masters Healthcare, LLC · Jul 2009
BAIXIN DISPOSABLE SYRINGE, MULTIPLE SIZES
K083686 · Anhui Kangda Medical Products Co., Ltd. · Jul 2009
XPRESSE INJECTION SYSTEM
K083583 · Nordson Efd · Jun 2009
STERILE HYPODERMIC SYRINGE AND NEEDLE FOR SINGLE USE, STERILE INSULING SYRINGE FOR SINGLE USE WITH FIXED NEEDLE
K090929 · Shanghai Double Dove Industrial Co., Ltd. · Jun 2009
COVIDIEN EXTENDED TIP APPLICATOR
K091315 · Confluent Surgical,Inc · Jun 2009